ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank
Recruiting
Observational Study
Focal Segmental Glomerulosclerosis
Proteinuria
Nephrotic Syndrome
Nephrotic Syndrome Steroid-Resistant
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- Up to 75
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Christoph Aufricht · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Nephrotic syndrome is the clinical phenotype of a heterogeneous group of glomerular diseases that may present with varying degrees of urinary protein loss (proteinuria), dysproteinemia in the blood, fluid retention and impaired renal function.
The AustRian RESistanT NEPHROtic Syndrome Treatment Response RegIStry and Biobank (ARREST-NEPHROSIS) sets out to achieve the following goals, as typical ca…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Resistant to standard Immunosuppressive agents (if clinically indicated, e.g. primary/non-genetic forms)
* Persistent urinary protein-to-creatinine (UP/C) ratio \>1.0 g/g
* eGFR \> 30 ml/min per 1.73 m2
* biopsy or a disease-causing genetic mutation associated with nephrotic s…
Contacts